GL

Gelesis

GLS·NYSEBoston MAFounded 2006100 employees
Micro CapbiotechPublicMetabolic
Platform: Hydrogel Obesity
Market Cap
$0.02B
All Drugs
2
Clinical Trials
4
Failed / Terminated
0
FDA Approved
1
Stock Price & Catalysts (GLS)
Loading GLS stock data...
Drug Pipeline (2 programs)
Drug NameCodePhaseTrialsModalityTargetMOAIndications
GLS-7714GLS-7714Approved2Small MoleculeKRASG12CDLL3 ADCALL
MotazasiranGLS-4357Preclinical2mAbBCMATROP-2 ADCHSACC
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (3)
2025-09-17
GLS-7714 Orphan Drug
ALL
Past
2026-03-14
Motazasiran Interim
ACC
Past
2026-04-06
Motazasiran Interim
ACC
Interim